Donate Now; ?>/img/team/team-9.jpg)
-
Patient Alaa praises 57357, saying: “CCHE57357 goes an extra mile to enable patients to defeat cancer ‘
-
Recent study by CCHE57357’s proteomics and Metabolomics team reveals: Two protein complexes were found to hinder a certain type of chemotherapy used in treating thyroid cancer
-
A recently published research by CCHE 57357’S Genomics team showcases a non-invasive diagnostic biomarker for Acute Myeloid leukemia patients
Egypt Cancer Network 57357 and AFNCI (ECN), a U.S. based 501c3 non-profit (Tax ID: 26-2192003) helping to further cancer education, research, and care as well as medical infrastructure in Egypt.
© 2021 ECN USA All Rights Reserved , powered by 